Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".
First Name
*
Last Name
*
Email Address
*
Email Address (Verify)
*
TOP Print Edition
We will request your mailing address on the next page.
JHOP/TOP E-Newsletters & Communications
I have reviewed and consent to the terms of
TOP
's
Privacy Policy
, and
TOP
has my permission to retain my information in its database, and to forward pertinent communications to me.
Home
Categories
Issues
2018
May 2018 - Vol 11 No 1
2017
November Vol 10 No 4
August Vol 10 No 3
May Vol 10 No 2
February Vol 10 No 1
2016
November Vol 9 No 4
August Vol 9 No 3
May Vol 9 No 2
February Vol 9 No 1
Issue Archive
Media Library
Video Library
Audiocast Library
News
In the News
Press Releases
CE
Supplements
Resources
Online Only
Conference Correspondent
ASHP 2016 - Oncology
About
About
Advertise
Editorial Board
Contact Us
Links
Submit
Author Guidelines
FDA News and Drug Updates
Welcome to the Third Annual Oncology Guide to New FDA Approvals
FDA Approvals in 2017 Represent a 21-Year High
FDA Approvals of Brand-Name Prescription Cancer Drugs in 2017
Alunbrig (Brigatinib) Approved for Metastatic NSCLC with ALK Mutation
Adverse Effects
Understanding Immunotherapy Late Adverse Effects in Cancer Survivors
Meg Barbor, MPH
Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer
Adverse Events Associated with Checkpoint Inhibitors
Alice Goodman
View All Supportive Care Articles
Immunotherapy
Which Combination Immunotherapies to Use, and When? High Response Rates, but Serious Toxicity Remains a Concern
Chase Doyle
Combining Immunotherapy and Radiotherapy Shows Good Synergy
Chase Doyle
Pembrolizumab Makes Inroads in Sarcoma Subtypes
Phoebe Starr
View All Breast Cancer Articles
Conference Correspondent
Palliative Care Use Dismal Among Patients with Hematologic Malignancies
Oral Multiple Myeloma Medication Linked to Decreased Productivity Loss
Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia
“Superhero” Navigators Convene at the 8th Annual Navigation & Survivorship Conference
Silent Patients Find Their Voices Through an Advocate’s Journey
View All Conference Correspondent Articles
Most Popular Articles
Giving People Hope as an Oncology Nurse
Laura Mulderrig, BSN, RN, OCN
Video Library
-
ONE Award, Video
FDA News - May 2018
TON - May 2018, Vol 11, No 2
-
FDA Approvals, News & Updates
Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer
TOP - May 2018, Vol 11, No 1
-
Adverse Effects, Breast Cancer
Alunbrig (Brigatinib) Approved for Metastatic NSCLC with ALK Mutation
Lisa A. Raedler, PhD, RPh, Medical Writer
2018 Third Annual Oncology Guide to New FDA Approvals
-
FDA Approvals, News & Updates, Lung Cancer
Welcome to the Third Annual Oncology Guide to New FDA Approvals
2018 Third Annual Oncology Guide to New FDA Approvals
-
FDA Approvals, News & Updates
Home
Categories
Issues
2018
May 2018 - Vol 11 No 1
2017
November Vol 10 No 4
August Vol 10 No 3
May Vol 10 No 2
February Vol 10 No 1
2016
November Vol 9 No 4
August Vol 9 No 3
May Vol 9 No 2
February Vol 9 No 1
Issue Archive
Media Library
Video Library
Audiocast Library
News
In the News
Press Releases
CE
Supplements
Resources
Online Only
Conference Correspondent
ASHP 2016 - Oncology
About
About
Advertise
Editorial Board
Contact Us
Links
Submit
Author Guidelines
